BMY · SUB~ · PE · Consorcio Bristol-Myers Squibb Peru S.A-Perufarma S.A.

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB PHARMA ~0.80' «Consorcio Bristol-Myers Squibb Peru S.A-Perufarma S.A.» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 3 non-competitive contracts at the buyer «DIRECCIÓN DE SANIDAD DE LA PNP», 44,381,109 PEN (≈ $11,982,899); one bid, method direct (Contratación Directa); OCID ocds-dgv273-seacev3-1173501, ocds-dgv273-seacev3-1221063, ocds-dgv273-seacev3-1220947; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject

BMY · SUB~ · PE · Consorcio Bristol-Myers Squibb Peru S.A-Perufarma S.A.

Indicator

Debarred / sanctioned abroad × US SEC issuer

Amount

11,982,899

Records behind the indicator

3

Found

4 October 2026

Code

W-02306

Reference

ocds-dgv273-seacev3-1173501

Reference

ocds-dgv273-seacev3-1221063

Reference

ocds-dgv273-seacev3-1220947

Reference

2015-10-05

Other records of this company10

1. 014 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
2. 024 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
3. 034 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
4. 044 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
5. 054 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
6. 064 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
7. 074 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
8. 084 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
9. 094 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
10. 104 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer